Oyekan HTN Flashcards
HTN increases the risk for _______
MI, kidney disease, and stroke
Causes of Secondary HTN
Disease States • Kidney disease • Adrenal gland tumors • Thyroid disease • Congenital blood vessel disorders • Alcohol abuse or chronic alcohol use • Obstructive sleep apnea
Drugs and Other Products
- NSAIDS
- Oral contraceptives
- Decongestants
- Cocaine
- Amphetamines
- Corticosteroids
- Foods
- Alcohol
RF for HTN regarding gender
Gender: Female >70 years of age; male <55 years of age
Primary hypertension
Overactivity of sympathetic nervous system and renin-angiotensin-aldosterone system (RAAS), and alterations in natriuretic peptides
Inflammation, endothelial dysfunction, obesity-related hormones, and insulin resistance
Genetics interact with diet, smoking, age, and other risk factors to cause chronic changes in vasomotor tone and blood volume.
Genetic factors like insulin resistance causes what affect in hypertension and what does it lead to?
Genetic factors like insulin resistance leads to VASOCONSTRICTION which increases systemic vascular resistance(^ SVR) and ultimately results and sustained hypertension
Environmental factors like inflammation leads to Reno salt and water with tension which increases the blood volume and ultimately result in sustained hypertension
Environmental factors like inflammation leads to renal salt and water retension which increases the blood volume and ultimately result in sustained hypertension
BP= CO * SVR
TX= Diuretics * Vasodilators
Stroke volume=
Stroke volume = EDV – ESV i.e. dependent on loading (pre-and afterload) and contractility
cardiac dysfunction i.e. pump-based hypertension requires what antiHTN medication?
cardiac dysfunction i.e. pump-based hypertension (↑ CO, normal SVR) in the younger patients. Calls for use of β- antagonists (BETA BLOCKERS)
Beta blockers cause the heart to beat more slowly and with less force, which lowers blood pressure. Beta blockers also help widen veins and arteries to improve blood flow.
vascular dysfunction i.e. vascular resistance-based hypertension requires what antiHTN medication?
vascular dysfunction i.e. vascular resistance-based hypertension (normal CO, ↑ SVR) in the elderly. Calls for use of DIURETICS
renal dysfunction i.e. volume-based Hypertension (↑ CO, ↑SVR), and neuroendocrine dysfunction involving excessive secretion of
- catecholamines (pheochromocytoma)
•aldosterone (primary aldosteronism)
•thyroid hormones (hyperthyroidism)
SYMPATHOLYTICS (SNS outflow blockers) consists of
- Ganglionic Blockers
- Postganglionic adrenergic nerve terminal antagonists
•a1-adrenergic antagonists
- B1-adrenergic antagonists
- Mixed a/B adrenergic antagonists
Vasodilators:
- CCB
- Minoxidil
+
*Hydralazine sodium
= K Channel openers
*Nitroprusside
What antiHTN medications affect HR?
- B-blockers (Beta blockers cause the heart to beat more slowly and with less force, which lowers blood pressure. Beta blockers also help widen veins and arteries to improve blood flow.)
- CCB (Calcium channel blockers are medications used to lower blood pressure. They work by preventing calcium from entering the cells of the heart and arteries. Calcium causes the heart and arteries to squeeze (contract) more strongly. By blocking calcium, calcium channel blockers allow blood vessels to relax and open.)
Stroke/blood volume is controlled by contractility and preload, what antiHTN medications tx contractility?
Bblockers
CCBs
Stroke/blood volume is controlled by contractility and preload(amount of VOLUME of blood in veins), what antiHTN medications tx preload(Vol)?
Venous tone:
- a1 antagonists
- sodium nitroprusside
- ACEI
- ATII antagonists
Intravascular VOLUME: (Na+/H20 retention):
- diuretics
- ACEI
- ATI antagonists
SVR is affected by direct innervation, circulator regulators, and local regulators, what anti-hypertension medications are used to treat direct innervation?
- a1 antagonists (The alpha-1 adrenergic receptor antagonists (also called alpha-blockers) are a family of agents that bind to and inhibit type 1 alpha-adrenergic receptors and thus inhibit smooth muscle contraction)
- central a2 AGONISTS
SVR is affected by direct innervation, circulator regulators, and local regulators, what anti-hypertension medications are used to treat circulating regulators?
- a1 antagonists
- central a2 agonists
- ACEI
- AT1 antagonists
SVR is affected by direct innervation, circulator regulators, and local regulators, what anti-hypertension medications are used to treat local regulators?
Endothelin antagonists
Sodium nitroprusside
ACE inhibitors
AT1 antagonists
TorF: Diuretics target Na+ reabsorption along every segment of the nephron
True
JNC7 recommends thiazide diuretics as the 1st line of treatment unless dictated otherwise such as patients with ______
JNC7 recommends thiazide diuretics as the 1st line of treatment unless dictated otherwise e.g. start with ACEIs in patients with diabetes.
__________ are effective in patients with volume-based hypertension characterized by renal dss and in African Americans.
Thiazide diuretics
SE of Thiazide diuretics
hypercalcemia, hyperuricemia, hyperglycemia, hyperlipidemia, HYPOkalemia
Major difference between different loop diuretics is:
Major difference between different loop diuretics is potency and incidence of allergies.
SE of loop diuretics
hypocalcemia, hypomagnessemia, metabolic alkalosis
volume-contraction alkalosis is often seen with what class of medications?
Loop diuretics
Loop diuretic uses:
1st line therapy for acute relief of edema in heart failure
Increase in Ca2+ diuresis in hyperparathyroidism and malignancy-associated hypercalciuria of parathyroid gland
Counteract hyperkalemia due to K+-retaining adverse effects of other drugs
ARF – useful to counteract decrease GFR of ARF